Reposal
Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2][3]
 | |
| Clinical data | |
|---|---|
| Other names | Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H18N2O3 |
| Molar mass | 262.304 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
  | |
References
- Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. I. Pharmacodynamic Activity". Ugeskrift for laeger (in Danish). 125: 1735–1738. PMID 14103836.
- Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. II. Clinical Effects". Ugeskrift for laeger (in Danish). 125: 1739–1741. PMID 14103837.
- Nielsen, P.; Tarding, F. (1968). "The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal)". Acta pharmacologica et toxicologica. 26 (6): 521–530. doi:10.1111/j.1600-0773.1968.tb00471.x. PMID 5756387.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.